Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036645 · ClinicalTrials.gov registry record · Phase 1
SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.
A Phase 1 study of Healthy Elderly and Mild-Moderate Alzheimer's Disease, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 77
- Enrollment target
- 10
- Study locations
NCT02036645 is a Phase 1 study of Healthy Elderly and Mild-Moderate Alzheimer's Disease that has completed, run by AstraZeneca. The registered enrollment target is 77 participants. The trial reports 10 study locations across 5 states.
The verdict
NCT02036645, a Phase 1 study of Healthy Elderly and Mild-Moderate Alzheimer's Disease, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 77 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.
Conditions Studied
Interventions
- BIOLOGICAL MEDI1814 for IV injection
- BIOLOGICAL MEDI1814 for Subcutaneous Injection
- BIOLOGICAL IV Placebo
- BIOLOGICAL Placebo for Subcutaneous Injection
Study Locations (10)
Florida
- Research Site - Hallandale
- Research Site - Hialeah
- Research Site - Miami
- Research Site - Orlando
California
- Research Site - Glendale
- Research Site - Long Beach
- Research Site - Panorama City
Maryland
- Research Site - Baltimore
Oklahoma
- Research Site - Oklahoma City
Utah
- Research Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-02-04 |
| Est. Completion | 2016-09-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02036645
The ClinicalTrials.gov registry entry for NCT02036645 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy Elderly appearing as the primary indexed condition, and to 4 interventions - of which MEDI1814 for IV injection is the first listed.
NCT02036645 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Florida, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT02036645 about?
NCT02036645 is a clinical study titled "SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.". The purpose of this study is to assess the safety, drug levels and effects on the body of 1 or 3 injections of MEDI1814, in people with mild to moderate Alzhiemer's Disease or healthy elderly people.
What is the current status of trial NCT02036645?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2014-02-04. Estimated completion is 2016-09-15.
What conditions does trial NCT02036645 study?
This clinical trial studies the following conditions: Healthy Elderly, Mild-Moderate Alzheimer's Disease.
What interventions are being tested in trial NCT02036645?
The interventions under investigation include: MEDI1814 for IV injection (BIOLOGICAL), MEDI1814 for Subcutaneous Injection (BIOLOGICAL), IV Placebo (BIOLOGICAL), Placebo for Subcutaneous Injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT02036645?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02036645 being conducted?
This trial has 10 study locations across California, Florida, Maryland, Oklahoma, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Elderly
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.